Advertisement

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px
Organisation › Details

Adrenomed AG

Adrenomed AG is a German privately financed, clinical-stage biopharmaceutical company. Adrenomed’s mission is to rescue vascular integrity in order to save the lives of critically ill patients with limited treatment options. Founded in 2009 by a management team with decades of in-depth experience in sepsis and deep knowledge in diagnostics and drug development, the company’s lead product candidate Adrecizumab (INN: enibarcimab) is a first-in-class non-blocking monoclonal antibody. Adrecizumab targets the vasoprotective peptide Adrenomedullin, an essential regulator of vascular integrity. Adrecizumab has successfully completed a biomarker-guided, double-blinded, placebo-controlled, randomized, multicenter proof-of-concept Phase II trial with 301 patients suffering from septic shock. *

 

Period Start 2010-10-20 established
Products Industry Adrecizumab
  Industry 2 drug development
Persons Person Jones, Richard (Adrenomed 202203– CEO before Fusion Antibodies formerly Novartis + GSK + Genzyme + Shire)
  Person 2 Bergmann, Andreas (Sphingotec GmbH 201301 Managing Director)
     
Region Region Hennigsdorf
  Country Germany
  Street 15a Neuendorfstr.
  City 16761 Hennigsdorf
  Tel +49-3302-207780
    Address record changed: 2022-09-17
     
Basic data Employees n. a.
     
    * Document for »About Section«: Adrenomed AG. (7/12/22). "Press Release: Adrenomed Appoints David Germonpré as Chief Financial Officer". Zurich.
     
   
Record changed: 2024-12-29

Advertisement

Picture Berlin Partner Top News Aignostics Mayo Clinic Pathology 650x200px

More documents for Adrenomed AG


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe Spring 2025 Milan to 28 Feb 650x300px




» top